This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
SEC.gov
EDGAR
Latest Filings
Filings search tools
Filing Detail
SEC Home
»
Company Search
»
Current Page
Form REGDEX
- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]:
SEC
Accession
No.
9999999997-03-033505
Filing Date
2003-08-25
Accepted
2003-08-26 11:32:46
Documents
1
Effectiveness Date
2003-08-25
Items
Item 06: Rule 506
Item UL:
Document Format Files
Seq
Description
Document
Type
Size
1
AUTO-GENERATED PAPER DOCUMENT
9999999997-03-033505.paper
REGDEX
150
Scanned paper document
scanned.pdf
471618
Complete submission text file
9999999997-03-033505.txt
1441
Mailing Address
Business Address
209 TENTH AVENUE SOUTH
SUITE 332
NASHVILLE,
TN
37203
CUMBERLAND PHARMACEUTICALS INC (Filer)
CIK
:
0001087294 (see all company filings)
Type:
REGDEX
| Act:
34
| File No.:
021-43359
| Film No.:
03030147